Literature DB >> 24478129

Association of neutrophil to lymphocyte ratio with presence and severity of gastritis due to Helicobacter pylori infection.

Raymond Farah1, Rola Khamisy-Farah.   

Abstract

OBJECTIVE: Infection with the bacterial pathogen Helicobacter pylori (HP) clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity and is the most frequent cause of dyspepsia and peptic disease. Some studies have shown that there was a correlation between low-grade inflammation as C-reactive protein (CRP) and HP infection. The aim of this study was to investigate the relationship between the presence of gastritis due to HP infection and neutrophil/lymphocyte ratio (NLR), a simple and reliable indicator of inflammation.
DESIGN: Fifty patients met the HP criteria and half of them have had severe symptoms and upper endoscopy showed atrophic gastritis, and fifty age- and sex-matched control subjects with gastritis without HP infection were included in this randomized controlled trial. Patients were diagnosed to have HP according to the use of urea breath testing (UBT) and multiple biopsies. NLR was calculated from complete blood count at the time of diagnosis and before initiating the treatment to all groups.
RESULTS: Patients with HP infection had significantly higher NLR compared to those without HP. Moreover, the patients with symptomatic HP and grade 4 gastritis had higher NLR than those asymptomatic with past history of peptic disease (P 0.007 and P 0.068, respectively). Although NLR increased as the severity of gastritis and HP symptoms increased (r = 0.564, P < 0.001), Receiver operating characteristic (ROC) Curve analysis was performed. The cut-off level for NLR with optimal sensitivity and specificity was calculated as 1.82 (area under curve [AUC] = 0.825 [0.753-0.884], P < 0.001).
CONCLUSION: The present study indicated, for the first time, a significant correlation between HP infection and inflammation on the basis of NLR, a simple and reliable indicator of inflammation. Furthermore, there is an increase in NLR as the severity of gastritis with HP increases. This elevated ratio gets normalized with treatment.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Helicobacter pylori; inflammation; neutrophil/lymphocyte ratio; peptic disease

Mesh:

Year:  2014        PMID: 24478129      PMCID: PMC6807333          DOI: 10.1002/jcla.21669

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  18 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

2.  Hematologic parameters and angiographic progression of coronary atherosclerosis.

Authors:  Nihat Kalay; Orhan Dogdu; Fatih Koc; Mikail Yarlioglues; Idris Ardic; Mahmut Akpek; Davran Cicek; Abdurrahman Oguzhan; Ali Ergin; Mehmet G Kaya
Journal:  Angiology       Date:  2011-07-06       Impact factor: 3.619

3.  Association of virulent Helicobacter pylori strains with ischemic heart disease.

Authors:  V Pasceri; G Cammarota; G Patti; L Cuoco; A Gasbarrini; R L Grillo; G Fedeli; G Gasbarrini; A Maseri
Journal:  Circulation       Date:  1998-05-05       Impact factor: 29.690

Review 4.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

Authors: 
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

5.  Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes.

Authors:  P Avanzas; R Arroyo-Espliguero; J Cosín-Sales; G Aldama; C Pizzi; J Quiles; J C Kaski
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

6.  The link between Helicobacter pylori infection and rosacea.

Authors:  A Szlachcic
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-07       Impact factor: 6.166

Review 7.  Transmission and epidemiology of Helicobacter pylori.

Authors:  D R Cave
Journal:  Am J Med       Date:  1996-05-20       Impact factor: 4.965

Review 8.  The prevalence of Helicobacter pylori infection in different countries.

Authors:  R E Pounder; D Ng
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

9.  Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease.

Authors:  Angela Papa; Michele Emdin; Claudio Passino; Claudio Michelassi; Debora Battaglia; Franca Cocci
Journal:  Clin Chim Acta       Date:  2008-05-01       Impact factor: 3.786

10.  Gastroenteritis and transmission of Helicobacter pylori infection in households.

Authors:  Sharon Perry; Maria de la Luz Sanchez; Shufang Yang; Thomas D Haggerty; Philip Hurst; Guillermo Perez-Perez; Julie Parsonnet
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

View more
  16 in total

1.  The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.

Authors:  Xingxing Tang; Peng Du; Yong Yang
Journal:  Int J Clin Oncol       Date:  2017-07-27       Impact factor: 3.402

2.  Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing.

Authors:  Nasibeh Vatankhah; Younes Jahangiri; Gregory J Landry; Robert B McLafferty; Nabil J Alkayed; Gregory L Moneta; Amir F Azarbal
Journal:  J Vasc Surg       Date:  2016-11-23       Impact factor: 4.268

3.  A link between platelet to lymphocyte ratio and Helicobacter pylori infection.

Authors:  Raymond Farah; Hamza Hamza; Rola Khamisy-Farah
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

4.  Association of TRPM5 Asn235Ser Polymorphism and Trace Elements/Minerals in Chronic Gastritis Patients: a Case-Control Study.

Authors:  G Koc; A Soyocak; D Duzgun Ergun; N Pastaci Ozsobaci; S Andac-Ozturk; S Ergun
Journal:  Biol Trace Elem Res       Date:  2021-11-12       Impact factor: 3.738

5.  Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.

Authors:  Binyi Xiao; Jianhong Peng; Rongxin Zhang; Jing Xu; Yongchun Wang; Yujing Fang; Junzhong Lin; Zhizhong Pan; Xiaojun Wu
Journal:  Cancer Manag Res       Date:  2017-11-27       Impact factor: 3.989

6.  Neutrophil to Lymphocyte Ratio in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Alime Gunes; Musa Yigit; Levent Tok; Ozlem Tok
Journal:  Korean J Ophthalmol       Date:  2017-03-21

7.  The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer.

Authors:  Mauricio Rivas; Francisco Acevedo; Francisco Dominguez; Hector Galindo; Mauricio Camus; David Oddo; Alejandra Villarroel; Dravna Razmilic; Jose Peña; Matias Munoz Medel; Maria Elena Navarro; Alejandra Perez-Sepulveda; Lidia Medina; Tomas Merino; Juan Briones; Alexis Kalergis; Cesar Sanchez
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

8.  Anatomical predilection of intestinal metaplasia based on 78,335 endoscopic cases.

Authors:  Xin-Yi Mao; Shun-Fu Xu; Qing Liu; Jian-Xia Jiang; Hai-Han Zhang; Huai-Ming Sang; Guo-Xin Zhang
Journal:  Saudi J Gastroenterol       Date:  2016 Mar-Apr       Impact factor: 2.485

9.  Association of Severity of Helicobacter pylori Infection with Peripheral Blood Neutrophil to Lymphocyte Ratio and Mean Platelet Volume.

Authors:  Mustafa Guclu; A Faruq Agan
Journal:  Euroasian J Hepatogastroenterol       Date:  2017-05-05

10.  The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer.

Authors:  Bo Wu; Shengchao Zhao; Yaru Sheng; Lu Ren; Guoquan Song
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.